Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Scott D. Solomon

11 ta ish

Harvard University

AkademScholarda batafsil koʻrsatkichlar

  1. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi +35

    Maqola20196 iqtibos
    ABI

  2. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

    John J.V. McMurray, Milton Packer, Akshay S. Desai +8

    Maqola20146 iqtibos
    ABI

  3. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

    Colin Baigent, Neeraj Bhala, Jonathan Emberson +27

    Sharh maqolaOchiq kirish20133 iqtibos
    ABI

  4. Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology

    Roberto M. Lang, Michelle Bierig, Richard B. Devereux +11

    Maqola20052 iqtibos
    ABI

  5. Spironolactone for Heart Failure with Preserved Ejection Fraction

    Bertram Pitt, Marc A. Pfeffer, Susan F. Assmann +20

    Maqola20142 iqtibos
    ABI

  6. Obesity and Subtypes of Incident Cardiovascular Disease

    Chiadi E. Ndumele, Kunihiro Matsushita, Mariana Lazo +9

    Maqola20162 iqtibos
    ABI

  7. Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

    Scott D. Solomon, John J.V. McMurray, Inder S. Anand +31

    Maqola20192 iqtibos
    ABI

  8. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure

    Scott D. Solomon, Muthiah Vaduganathan, Brian Claggett +22

    Maqola20192 iqtibos
    ABI

  9. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

    David Adams, Alejandra González‐Duarte, William O’Riordan +33

    Maqola20182 iqtibos
    ABI

  10. Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone

    Amil M. Shah, Brian Claggett, Nancy K. Sweitzer +6

    Maqola20152 iqtibos
    ABI

  11. Recovery of cardiac function following <scp>COVID</scp> ‐19 –  <scp>ECHOVID</scp> ‐19: a prospective longitudinal cohort study

    Mats Christian Højbjerg Lassen, Kristoffer Grundtvig Skaarup, Jannie Nørgaard Lind +27

    Maqola20212 iqtibos
    ABI